A proprietary chemistry platform from the laboratory of Dr. Andrei Yudin at the University of Toronto allows efficient synthesis of uniquely substituted ring systems comprising six to twenty or more contiguous atoms. Our core Discovery capability focuses on the design of molecules that address emerging principles in the chemical space required to mediate protein-protein interactions. The company's collaborative programs reflect the evolving understanding in this space and in the identification of key drug targets.
View Top Employees from Encycle Therapeutics IncWebsite | http://www.encycletherapeutics.com |
Revenue | $811000 |
Funding | $3 million |
Employees | 6 (0 on RocketReach) |
Founded | 2012 |
Address | 101 College St Ste 314, Toronto, Ontario M5G 1L7, CA |
Phone | (647) 258-4500 |
Technologies |
JavaScript,
HTML,
PHP
+13 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Chemical, Therapeutics, Health Care |
Web Rank | 22 Million |
Competitors | Aileron Therapeutics, Bicycle Therapeutics, Cyclenium Pharma Inc., Lamda Biotech Inc, Therapeutic Frontiers Ltd |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies |
Looking for a particular Encycle Therapeutics Inc employee's phone or email?
The Encycle Therapeutics Inc annual revenue was $811000 in 2023.
Encycle Therapeutics Inc is based in Toronto, Ontario.
The NAICS codes for Encycle Therapeutics Inc are [541, 54, 541714, 54171, 5417].
The SIC codes for Encycle Therapeutics Inc are [873, 87].